© Shutterstock
Ad
Continuous
surveillance of the NB.1.8.1 variant (12/12)
In conclusion, although the NB.1.8.1 variant is not yet a major threat, its rapid spread and mutations require continuous surveillance. Vaccines remain our best defence, and public health measures must be strengthened to limit its spread.
